This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Diagnosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The criteria for diagnosis of this syndrome has been outlined by the American College of Rheumatology. The six classification criteria identified in the study were:

  • asthma
  • peripheral blood eosinophilia
  • neuropathy
  • pulmonary infiltrates
  • paranasal sinus involvement
  • biopsy showing vasculitis with extravascular eosinophils

The presence of four of these criteria permitted discrimination of Churg-Strauss syndrome from other vasculitidies with a sensitivity of 85% and a specificity of 99.7%.

Laboratory diagnosis is based on tissue biopsy and the antineutrophil cytoplasmic antibody (ANCA) test

  • serologically, the prevalence of ANCA is anti-MPO pANCA 60% and anti-PR3 cANCA 10% and undetected in the remaining 20% (2)

This syndrome is also characterised by elevated levels of IgE.

Reference:

  • (1) Mais AT et al.Arthritis Rheum 1990; 33: 1094-1100.
  • (2) Davies DJ. Small vessel vasculitis. Cardiovascular Pathology 2005; 14 (6): 335-346.
  • (3) Savage COS. Systemic vasculitides.Medicine International 1994;22(2): 53-7.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.